glp 1 eyesight Emerging Concerns: GLP-1 Modulators and Their Potential Risk to Vision Blindness and GLP-1 Drugs: An
Description
Accessed September 19, 2018

For people with type 2 diabetes, the STEP-2 trial showed average weight loss of around 9.6% on the 2.4mg dose, roughly 64% of the result in people without diabetes 4
That is the problem with most reviews of telehealth weight loss programs

[DOI] [PubMed] [Google Scholar] 39.Bradley M., Melchor J., Carr R., Karjoo S

Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trials
So thats great